Search Results

There are 22334 results for: content related to: Optical fiber-based in vivo quantification of growth factor receptors

  1. You have free access to this content
    Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression-free survival in patients with HER2-positive metastatic breast cancer receiving lapatinib monotherapy

    Cancer

    Volume 117, Issue 21, 1 November 2011, Pages: 5013–5020, Allan Lipton, Kim Leitzel, Suhail M. Ali, Walter Carney, Greg Platek, Klaudia Steplewski, Ron Westlund, Robert Gagnon, Anne-Marie Martin and Julie Maltzman

    Article first published online : 31 MAR 2011, DOI: 10.1002/cncr.26101

  2. You have free access to this content
    Calpain4 is required for activation of HER2 in breast cancer cells exposed to trastuzumab and its suppression decreases survival and enhances response

    International Journal of Cancer

    Volume 131, Issue 10, 15 November 2012, Pages: 2420–2432, Sucheta Kulkarni, Leya Saju, Carol Farver and Raymond Tubbs

    Article first published online : 28 MAR 2012, DOI: 10.1002/ijc.27510

  3. Trastuzumab containing regimens for early breast cancer

    Intervention Review

    The Cochrane Library

    Lorenzo Moja, Ludovica Tagliabue, Sara Balduzzi, Elena Parmelli, Vanna Pistotti, Valentina Guarneri and Roberto D'Amico

    Published Online : 18 APR 2012, DOI: 10.1002/14651858.CD006243.pub2

  4. Trastuzumab-containing regimens for metastatic breast cancer

    Intervention Review

    The Cochrane Library

    Sara Balduzzi, Stefania Mantarro, Valentina Guarneri, Ludovica Tagliabue, Vanna Pistotti, Lorenzo Moja and Roberto D'Amico

    Published Online : 12 JUN 2014, DOI: 10.1002/14651858.CD006242.pub2

  5. You have full text access to this Open Access content
    Mechanisms of resistance to anti-human epidermal growth factor receptor 2 agents in breast cancer

    Cancer Science

    Volume 102, Issue 1, January 2011, Pages: 1–8, Toru Mukohara

    Article first published online : 6 SEP 2010, DOI: 10.1111/j.1349-7006.2010.01711.x

  6. Systemic therapy for early-stage HER2-positive breast cancers: Time for a less-is-more approach?

    Cancer

    Volume 121, Issue 4, February 15, 2015, Pages: 517–526, Elisavet Paplomata, Rita Nahta and Ruth M. O'Regan

    Article first published online : 24 OCT 2014, DOI: 10.1002/cncr.29060

  7. You have free access to this content
    Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo

    International Journal of Cancer

    Volume 126, Issue 12, 15 June 2010, Pages: 2893–2903, Michael A. Morse, Junping Wei, Zachary Hartman, Wenle Xia, Xiu-Rong Ren, Gangjun Lei, William T. Barry, Takuya Osada, Amy C. Hobeika, Sharon Peplinski, Haixiang Jiang, Gayathri R. Devi, Wei Chen, Neil Spector, Andrea Amalfitano, H. Kim Lyerly and Timothy M. Clay

    Article first published online : 23 OCT 2009, DOI: 10.1002/ijc.24995

  8. Imaging EGFR and HER2 by PET and SPECT: A Review

    Medicinal Research Reviews

    Volume 34, Issue 3, May 2014, Pages: 596–643, Emily B. Corcoran and Robert N. Hanson

    Article first published online : 29 AUG 2013, DOI: 10.1002/med.21299

  9. You have free access to this content
    Management of patients with HER2-positive metastatic breast cancer: Is there an optimal sequence of HER2-directed approaches?

    Cancer

    Volume 121, Issue 1, January 1, 2015, Pages: 17–24, Amelia B. Zelnak and Kari B. Wisinski

    Article first published online : 23 JUL 2014, DOI: 10.1002/cncr.28815

  10. You have free access to this content
    Targeting endothelin A receptor enhances anti-proliferative and anti-invasive effects of the HER2 antibody trastuzumab in HER2-overexpressing breast cancer cells

    International Journal of Cancer

    Volume 127, Issue 3, 1 August 2010, Pages: 696–706, Jeanett Fischgräbe, Martin Götte, Katharina Michels, Ludwig Kiesel and Pia Wülfing

    Article first published online : 3 DEC 2009, DOI: 10.1002/ijc.25076

  11. Understanding the HER family in breast cancer: interaction with ligands, dimerization and treatments

    Histopathology

    Volume 56, Issue 5, April 2010, Pages: 560–572, Fabrício F T Barros, Desmond G Powe, Ian O Ellis and Andrew R Green

    Article first published online : 30 MAR 2010, DOI: 10.1111/j.1365-2559.2010.03494.x

    Corrected by:

    Corrigendum

    Vol. 56, Issue 7, 986, Article first published online: 7 JUN 2010

  12. The sensitivity of gastric cancer to trastuzumab is regulated by the miR-223/FBXW7 pathway

    International Journal of Cancer

    Volume 136, Issue 7, 1 April 2015, Pages: 1537–1545, Kojiro Eto, Masaaki Iwatsuki, Masayuki Watanabe, Takatsugu Ishimoto, Satoshi Ida, Yu Imamura, Shiro Iwagami, Yoshifumi Baba, Yasuo Sakamoto, Yuji Miyamoto, Naoya Yoshida and Hideo Baba

    Article first published online : 11 SEP 2014, DOI: 10.1002/ijc.29168

  13. You have free access to this content
    Systemic treatment of HER2+ metastatic breast cancer: Clinical conundrums and future perspectives

    Asia-Pacific Journal of Clinical Oncology

    Volume 10, Issue S4, June 2014, Pages: 15–25, Richard De Boer, Jane Beith, Jacquie Chirgwin, Sue Chua, Maree Colosimo, Prudence Francis, Michael Green, Ken Pittman, Michelle White, Nicholas Wilcken, Nicholas Zdenkowski and Richard Bell

    Article first published online : 6 MAY 2014, DOI: 10.1111/ajco.12207

  14. Comparison of intratumoral heterogeneity of HER2 expression between primary tumor and multiple organ metastases in gastric cancer: Clinicopathological study of three autopsy cases and one resected case

    Pathology International

    Takuya Saito, Chihiro Kondo, Kohei Shitara, Yuichi Ito, Noriko Saito, Yuzuru Ikehara, Yasushi Yatabe, Keigo Yamamichi, Hideo Tanaka and Hayao Nakanishi

    Article first published online : 31 MAR 2015, DOI: 10.1111/pin.12290

  15. Primary trastuzumab resistance: new tricks for an old drug

    Annals of the New York Academy of Sciences

    Volume 1210, Issue 1, October 2010, Pages: 53–65, Jason A. Wilken and Nita J. Maihle

    Article first published online : 25 OCT 2010, DOI: 10.1111/j.1749-6632.2010.05782.x

  16. Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer

    Clinical Pharmacology & Therapeutics

    Volume 87, Issue 5, May 2010, Pages: 586–592, E C Dijkers, T H Oude Munnink, J G Kosterink, A H Brouwers, P L Jager, J R de Jong, G A van Dongen, C P Schröder, M N Lub-de Hooge and E G de Vries

    Article first published online : 31 MAR 2010, DOI: 10.1038/clpt.2010.12

  17. You have free access to this content
    Hormone-receptor expression and activity of trastuzumab with chemotherapy in HER2-positive advanced breast cancer patients

    Cancer

    Volume 118, Issue 1, 1 January 2012, Pages: 17–26, Filippo Montemurro, Valentina Rossi, Maria Cossu Rocca, Rossella Martinello, Elena Verri, Stefania Redana, Laura Adamoli, Giorgio Valabrega, Anna Sapino, Massimo Aglietta, Giuseppe Viale, Aron Goldhirsch and Franco Nolè

    Article first published online : 19 MAY 2011, DOI: 10.1002/cncr.26162

  18. You have free access to this content
    Systemic treatment of HER2-positive metastatic breast cancer: A systematic review

    Asia-Pacific Journal of Clinical Oncology

    Volume 10, Issue S4, June 2014, Pages: 1–14, Nicholas Wilcken, Nicholas Zdenkowski, Michelle White, Ray Snyder, Ken Pittman, Paul Mainwaring, Michael Green, Prudence Francis, Richard De Boer, Maree Colosimo, Sue Chua, Jacquie Chirgwin, Jane Beith and Richard Bell

    Article first published online : 6 MAY 2014, DOI: 10.1111/ajco.12206

  19. You have free access to this content
    Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization-positive patients with metastatic breast cancer treated with trastuzumab

    Cancer

    Volume 116, Issue 22, 15 November 2010, Pages: 5168–5178, Allan Lipton, Wolfgang J. Köstler, Kim Leitzel, Suhail M. Ali, Jeff Sperinde, Jodi Weidler, Agnes Paquet, Thomas Sherwood, Weidong Huang, Michael Bates and the Trastuzumab Response Biomarker Group

    Article first published online : 3 NOV 2010, DOI: 10.1002/cncr.25430

  20. You have free access to this content
    Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients

    Cancer

    Volume 118, Issue 10, 15 May 2012, Pages: 2603–2614, Eun-Jung Jung, Libero Santarpia, Juyeon Kim, Francisco J. Esteva, Erica Moretti, Aman U. Buzdar, Angelo Di Leo, Xiao-Feng Le, Robert C. Bast Jr, Soon-Tae Park, Lajos Pusztai and George A. Calin

    Article first published online : 5 OCT 2011, DOI: 10.1002/cncr.26565